Approval · Notice of Compliance 17153 · 2015
ZOLMITRIPTAN: Notice of Compliance 17153
Issued July 31, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17153
- Date
- July 31, 2015
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- 5-HT1 Receptor Agonist, Migraine Therapy
- Canadian reference product
- ZOMIG, ZOMIG RAPIMELT (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLMITRIPTAN | 02442655 | Dormant |
| ZOLMITRIPTAN ODT | 02442671 | Dormant |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB